Office-based chemical procedures for tendons

Caroline Schepker; Xiaoning Yuan; Zachary Bailowitz; Christopher Visco

doi:10.1007/978-3-030-65335-4_20

Office-based chemical procedures for tendons

Caroline Schepker^*, Xiaoning Yuan, Zachary Bailowitz, Christopher Visco

^*Corresponding author for this work

Physical Medicine and Rehabilitation

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Prolotherapy is an injection-based treatment that seeks to induce tissue healing and repair through the introduction of irritating solutions into soft tissue structures. Modern practice of prolotherapy is conventionally aimed at addressing various musculoskeletal complaints including pain, instability, and laxity attributable to either overt or microtrauma within supporting connective tissue structures. Prolotherapy is distinct from other regenerative techniques in that its injectate lacks a biologic agent. Mild-to-moderate evidence exists for the use of hyperosmolar dextrose solutions to address ligamentous injuries, osteoarthritis, and tendinopathy; however, injection protocols are heterogenous, and a unifying consensus on best practice for various conditions has not yet been established.

Original language	English
Title of host publication	Tendinopathy
Subtitle of host publication	From Basic Science to Clinical Management
Publisher	Springer International Publishing
Pages	347-353
Number of pages	7
ISBN (Electronic)	9783030653354
ISBN (Print)	9783030653347
DOIs	https://doi.org/10.1007/978-3-030-65335-4_20
State	Published - 9 Jun 2021

Keywords

Dextrose
Injection therapy
Instability
Joint pain
Laxity
Prolotherapy
Regenerative medicine
Tendinopathy
Tendinosis
Tendon

Access to Document

10.1007/978-3-030-65335-4_20

Cite this

@inbook{988160404fe5407c882b65173c8588d0,

title = "Office-based chemical procedures for tendons",

abstract = "Prolotherapy is an injection-based treatment that seeks to induce tissue healing and repair through the introduction of irritating solutions into soft tissue structures. Modern practice of prolotherapy is conventionally aimed at addressing various musculoskeletal complaints including pain, instability, and laxity attributable to either overt or microtrauma within supporting connective tissue structures. Prolotherapy is distinct from other regenerative techniques in that its injectate lacks a biologic agent. Mild-to-moderate evidence exists for the use of hyperosmolar dextrose solutions to address ligamentous injuries, osteoarthritis, and tendinopathy; however, injection protocols are heterogenous, and a unifying consensus on best practice for various conditions has not yet been established.",

keywords = "Dextrose, Injection therapy, Instability, Joint pain, Laxity, Prolotherapy, Regenerative medicine, Tendinopathy, Tendinosis, Tendon",

author = "Caroline Schepker and Xiaoning Yuan and Zachary Bailowitz and Christopher Visco",

year = "2021",

month = jun,

day = "9",

doi = "10.1007/978-3-030-65335-4_20",

language = "English",

isbn = "9783030653347",

pages = "347--353",

booktitle = "Tendinopathy",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Office-based chemical procedures for tendons

AU - Schepker, Caroline

AU - Yuan, Xiaoning

AU - Bailowitz, Zachary

AU - Visco, Christopher

PY - 2021/6/9

Y1 - 2021/6/9

N2 - Prolotherapy is an injection-based treatment that seeks to induce tissue healing and repair through the introduction of irritating solutions into soft tissue structures. Modern practice of prolotherapy is conventionally aimed at addressing various musculoskeletal complaints including pain, instability, and laxity attributable to either overt or microtrauma within supporting connective tissue structures. Prolotherapy is distinct from other regenerative techniques in that its injectate lacks a biologic agent. Mild-to-moderate evidence exists for the use of hyperosmolar dextrose solutions to address ligamentous injuries, osteoarthritis, and tendinopathy; however, injection protocols are heterogenous, and a unifying consensus on best practice for various conditions has not yet been established.

AB - Prolotherapy is an injection-based treatment that seeks to induce tissue healing and repair through the introduction of irritating solutions into soft tissue structures. Modern practice of prolotherapy is conventionally aimed at addressing various musculoskeletal complaints including pain, instability, and laxity attributable to either overt or microtrauma within supporting connective tissue structures. Prolotherapy is distinct from other regenerative techniques in that its injectate lacks a biologic agent. Mild-to-moderate evidence exists for the use of hyperosmolar dextrose solutions to address ligamentous injuries, osteoarthritis, and tendinopathy; however, injection protocols are heterogenous, and a unifying consensus on best practice for various conditions has not yet been established.

KW - Dextrose

KW - Injection therapy

KW - Instability

KW - Joint pain

KW - Laxity

KW - Prolotherapy

KW - Regenerative medicine

KW - Tendinopathy

KW - Tendinosis

KW - Tendon

UR - http://www.scopus.com/inward/record.url?scp=85150931522&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-65335-4_20

DO - 10.1007/978-3-030-65335-4_20

M3 - Chapter

AN - SCOPUS:85150931522

SN - 9783030653347

SP - 347

EP - 353

BT - Tendinopathy

PB - Springer International Publishing

ER -